Plasma metabolite profiling of chronic myeloid leukemia patients

摘要

The study of plasma metabolic profile in CML patients was accomplished. The results revealed differences in metabolite levels of the groups treated with tyrosine kinase inhibitors, patients before treatment and healthy controls.